Prescription drug · NDA
Xylocaine Mpf (Lidocaine hydrochloride) NDC 51662-1654
Lidocaine hydrochloride anhydrous 10 mg/mL · Injection, Solution · Epidural, Infiltration, Intracaudal, Perineural · HF Acquisition Co LLC, DBA HealthFirst
NDC codes
FDA NDC DirectoryProduct NDC (as listed)51662-1654Labeler and product segments. Claims need a package NDC.
Product NDC at billing width51662-1654Add the package segment from the table below.
| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51662-1654-1 | 5166216540151662165401 | 5 mL in 1 VIAL, SINGLE-DOSE (51662-1654-1)Marketed from Aug 12, 2010 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Xylocaine Mpf
- Generic name (nonproprietary)
- lidocaine hydrochloride
- Active ingredients
- Lidocaine hydrochloride anhydrous — 10 mg/mL
- Dosage form
- Injection, Solution
- Route
- Epidural, Infiltration, Intracaudal, Perineural
- Labeler
- HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 006488
- Marketing start
- Listing expires
- Other FDA classes
- Amides (Chemical structure)Local Anesthesia (Physiologic effect)
- Identifiers
- Product ID 51662-1654_26fa4a7f-74c4-0496-e063-6394a90a2bdcSPL ID 26fa4a7f-74c4-0496-e063-6394a90a2bdcSPL set ID 199ac3eb-1fa5-9cf5-e063-6394a90a7228RxCUI 1737566, 1737567UNII EC2CNF7XFP
- Pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N451662165401followed by a unit qualifier and the quantityPackage 51662-1654-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.
Excerpt only. Read the full label for complete information.
About NDC 51662-1654
- What is NDC 51662-1654?
- 51662-1654 is the product NDC for Xylocaine Mpf (lidocaine hydrochloride), Lidocaine hydrochloride anhydrous 10 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Xylocaine Mpf (Lidocaine hydrochloride).
- What is the active ingredient?
- Lidocaine hydrochloride anhydrous.
- Who is the labeler?
- HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Xylocaine Mpf?
- 14 other product NDCs are listed under this name. See all Xylocaine Mpf NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Xylocaine Mpf products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 65219-810 | 65219-0810-02 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 65219-812 | 65219-0812-02 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 65219-814 | 65219-0814-05 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-492 | 63323-0492-97 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 15 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-493 | 63323-0493-9163323-0493-97 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-496 | 63323-0496-97 |
| Xylocaine Mpf | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | HF Acquisition Co LLC, DBA HealthFirst | 51662-1644 | 51662-1644-01 |
| Xylocaine Mpflidocaine hydrochloride | Lidocaine hydrochloride anhydrous 5 mg/mL | Injection, SolutionInfiltration | HF Acquisition Co LLC, DBA HealthFirst | 51662-1653 | 51662-1653-01 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-487 | 63323-0487-1763323-0487-3163323-0487-37 |
| Xylocaine MPFlidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 15 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-488 | 63323-0488-1763323-0488-3163323-0488-37 |
Other NDCs under NDA 006488
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Xylocainelidocaine hydrochloride and epinephrine | Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Henry Schein, Inc. | 0404-9972 |
| XYLOCAINE- MPF (LIDOCAINE HCl )lidocaine hcl | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | HF Acquisition Co LLC, DBA HealthFirst | 51662-1604 |
| Xylocaine | Epinephrine bitartrate .01 mg/mL; Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | HF Acquisition Co LLC, DBA HealthFirst | 51662-1622 |
| Xylocainelidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-482 |
| Xylocainelidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 5 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-481 |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-485 |
| Xylocainelidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-482 |
| Xylocainelidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-483 |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 5 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-484 |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-485 |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-486 |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-486 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 5 mg/mL | Injection, SolutionInfiltration | Fresenius Kabi USA, LLC | 63323-491 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-487 |
| Xylocaine MPFlidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 15 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-488 |
| Xylocaine MPFlidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-489 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 15 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-493 |
| Xylocaine Mpf | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | HF Acquisition Co LLC, DBA HealthFirst | 51662-1644 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-492 |
| Xylocaine | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | HF Acquisition Co LLC, DBA HealthFirst | 51662-1645 |
Showing 20 of 39.